Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation

BACKGROUND/AIMS: The dose of mycophenolate mofetil (MMF) has been reduced in Asia due to side effects associated with the conventional fixed dose of 2-3 g/day. We aimed to determine the pharmacokinetics of a reduced dose of MMF and to validate its feasibility in combination with tacrolimus in living...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kim, Hyeyoung, Yi, Nam-Joon, Lee, Juyeun, Kim, Joohyun, Moon, Mi-Ra, Jeong, Jaehong, Lee, Jeong-Moo, You, Tae Suk, Suh, Suk-Won, Park, Min-Su, Choi, YoungRok, Hong, Geun, Lee, Hae Won, Lee, Kwang-Woong, Suh, Kyung-Suk
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Association for the Study of the Liver 2014
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4197178/
https://ncbi.nlm.nih.gov/pubmed/25320733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2014.20.3.291
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados